Literature DB >> 11514708

Allergen exposure and the development of asthma.

R Sporik1, T A Platts-Mills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11514708      PMCID： PMC1765986     

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  70 in total

1.  The protective effect of childhood infections.

Authors:  S L Johnston; P J Openshaw
Journal:  BMJ       Date:  2001-02-17

2.  Cord blood-IgE as risk factor and predictor for atopic diseases.

Authors:  G Edenharter; R L Bergmann; K E Bergmann; V Wahn; J Forster; F Zepp; U Wahn
Journal:  Clin Exp Allergy       Date:  1998-06       Impact factor: 5.018

3.  Prevalence and severity of asthma, rhinitis, and atopic eczema: the north east study.

Authors:  M H Shamssain; N Shamsian
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

4.  Serum IgE levels during the first 6 years of life.

Authors:  M Kulig; U Tacke; J Forster; G Edenharter; R Bergmann; S Lau; V Wahn; F Zepp; U Wahn
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

5.  Effect of pre- and postnatal tobacco smoke exposure on specific sensitization to food and inhalant allergens during the first 3 years of life. Multicenter Allergy Study Group, Germany.

Authors:  M Kulig; W Luck; S Lau; B Niggemann; R Bergmann; U Klettke; I Guggenmoos-Holzmann; U Wahn
Journal:  Allergy       Date:  1999-03       Impact factor: 13.146

6.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

7.  Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study.

Authors:  M Kulig; R Bergmann; B Niggemann; G Burow; U Wahn
Journal:  Clin Exp Allergy       Date:  1998-11       Impact factor: 5.018

8.  Atopic dermatitis in early infancy predicts allergic airway disease at 5 years.

Authors:  R L Bergmann; G Edenharter; K E Bergmann; J Forster; C P Bauer; V Wahn; F Zepp; U Wahn
Journal:  Clin Exp Allergy       Date:  1998-08       Impact factor: 5.018

Review 9.  Methods and effectiveness of environmental control.

Authors:  E Tovey; G Marks
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793

10.  Determinants of house dust mite allergen in homes in Wellington, New Zealand.

Authors:  K Wickens; R Siebers; I Ellis; S Lewis; G Sawyer; S Tohill; L Stone; R Kent; J Kennedy; T Slater; A Crothall; H Trethowen; N Pearce; P Fitzharris; J Crane
Journal:  Clin Exp Allergy       Date:  1997-09       Impact factor: 5.018
View more
  10 in total

1.  Indoor allergens, asthma, and asthma-related symptoms among adolescents in Wuhan, China.

Authors:  Päivi M Salo; Jiang Xia; C Anderson Johnson; Yan Li; Edward L Avol; Jie Gong; Stephanie J London
Journal:  Ann Epidemiol       Date:  2004-09       Impact factor: 3.797

Review 2.  Potential roles in rhinitis for protease and other enzymatic activities of allergens.

Authors:  Nita Sehgal; Adnan Custovic; Ashley Woodcock
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

3.  A side-by-side comparison of three allergen sampling methods in settled house dust.

Authors:  Megan Sandel; Johnna S Murphy; Sherry L Dixon; John L Adgate; Ginger L Chew; Samuel Dorevitch; David E Jacobs
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-05-07       Impact factor: 5.563

4.  Possible reasons for lack of effect of allergen avoidance in atopy-prone infants and sensitive asthmatic patients.

Authors:  I Romei; Attilio L Boner
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

5.  Targeting immunoglobulin E as a novel treatment for asthma.

Authors:  Thomas Sandström
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

6.  Omalizumab in the management of patients with allergic (IgE-mediated) asthma.

Authors:  Thomas Sandström
Journal:  J Asthma Allergy       Date:  2009-05-08

7.  Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.

Authors:  Wanda Phipatanakul; David T Mauger; Theresa W Guilbert; Leonard B Bacharier; Sandy Durrani; Daniel J Jackson; Fernando D Martinez; Anne M Fitzpatrick; Amparito Cunningham; Susan Kunselman; Lisa M Wheatley; Cindy Bauer; Carla M Davis; Bob Geng; Kirsten M Kloepfer; Craig Lapin; Andrew H Liu; Jacqueline A Pongracic; Stephen J Teach; James Chmiel; Jonathan M Gaffin; Matthew Greenhawt; Meera R Gupta; Peggy S Lai; Robert F Lemanske; Wayne J Morgan; William J Sheehan; Jeffrey Stokes; Peter S Thorne; Hans C Oettgen; Elliot Israel
Journal:  Contemp Clin Trials       Date:  2020-11-24       Impact factor: 2.261

Review 8.  The asthma epidemic and our artificial habitats.

Authors:  Wasim Maziak
Journal:  BMC Pulm Med       Date:  2005-03-31       Impact factor: 3.317

9.  Exploring the effect of presence and type of allergen sensitization on fractional exhaled nitric oxide, immunoglobulin E, and interleukins 4, 5, and 13 among asthmatics.

Authors:  Nipun Malhotra; Nitesh Gupta; Raj Kumar
Journal:  Lung India       Date:  2020 Jul-Aug

10.  In vivo-to-in silico iterations to investigate aeroallergen-host interactions.

Authors:  Alba Llop-Guevara; Marc Colangelo; Derek K Chu; Cheryl Lynn Moore; Nicole A Stieber; Tina D Walker; Susanna Goncharova; Anthony J Coyle; Lennart K A Lundblad; Paul M O'Byrne; Miroslav Lovric; Manel Jordana
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.